At Qcil, we believe that everyone should have access to lifesaving medication. In the crusade against HIV, Qcil has manufactured medication that has revolutionised HIV treatment, changing it from something which was previously considered a death sentence, to something which can be managed like any other chronic condition.
In 2001, Qcil was the first in Africa to introduce the innovative 3-in-1 fixed dose combination (Stavudine + Lamivudine + Nevirapine), to fight HIV/AIDS. It was made available at less than $1 per day, compared to over $12,000 per patient per year, prevailing in Uganda and most countries around the world.
Qcil produces groundbreaking medication that has revolutionized HIV therapy, enabling people living with HIV to lead normal lives, provided they adhere to their treatment. We are also dedicated to educating the public about the importance of knowing their HIV status and actively working to end the stigma surrounding HIV/AIDS.
#LifeAfterWell
#EndStigma
#KnowYourStatus
“This is who I am, I am defined by HIV but not limited by it.” This is the story of Barbara, who was a victim of sexual assault by her uncles as a child. She embraced her HIV status against all odds, got married and has a happy family.
Born with HIV, Henry from Kamwokya shares his life story—from discovering his HIV status as a child to battling rejection and stigma in his community. We follow his courageous journey as he becomes an activist for the environment.
300mg
50mg/300mg/300mg
400mg/300mg/300mg
150mg / 300 mg
For product sales, please contact us at sales@qcil.com or visit our Qcare app: https://qcare.qcil.com/
The products shown should not be consumed based on information provided by Qcil. Please visit your healthcare practitioner for medical advice.
We have played a significant role in the management of Hepatitis B and C, through the production of a wide range of drug treatments.
Read more